Abstract: In viva gene transfer and RNase protection assay were used to follow thyroid hormone (T,)-dependent regulation of myosin heavy chain (myHC) genes in Xenopus tadpole dorsal muscle. One embryonic and one adult myHC form were measured by each approach. RNase protection assay showed that T, decreased expression of endogenous embryonic mRNA (E3), but increased adult (A7) transcripts. Gene transfer showed that T, exerted transcriptional effects on mammalian embryonic and adult myHc promoters injected into the same muscle. The kinetics and profiles of the transcriptional responses were superimposable on endogenous responses. The results strengthen the use of in viva approaches for determining the roles of transcription factors and cis-regulatory sequences in integrated contexts.
Introduction
Application of in viva gene transfer techniques to fundamental research should permit the analysis of either the function of a protein or the regulation of gene expression within an integrated context (1). In particular, somatic nonviral gene transfer approaches should provide versatile alternatives to germ cell-modified transgenic animals as they have the advantage of being easily applicable to a wide range of species at different developmental stages. But before these powerful techniques can be fully exploited a number of problems have to be resolved. Two critical factors are the efficiency of transfer and whether the regulations observed are physiologically relevant. Previous work on Xenopus skeletal muscle (2) and on mammalian cardiac muscle (3) established that physiological regulations could be studied by the direct injection of DNA into muscle. However, it is also important to establish whether there are parallel regulations of endogenous and exogenous genes in the same physiological setting and whether genes can be analysed in a heterologous context. Amphibian metamorphosis is an excellent model for studying T, effects on gene expression during vertebrate post-embryonic development as T,-dependent processes can be manipulated in the free living animal. We used this model to follow T, effects on expression of embryonic and adult myHC isoforms in the dorsal muscle and to test the validity We thank the Biophysics Laboratory, MNHN, Paris, for use of their Phosphoimager. We are grateful to Dr. B. Abdallah for critical reading of the manuscript. This work was funded by grants from the Association pour la Recherche contre le Cancer (ARC), and the Association FranFaise contre les Myopathies (AFM 
Materials and Methods
Animals : Xenopus laevis tadpoles were raised as described (2). Tadpoles at stages NF52-53 (4) were transferred to aquaria containing 0.1% sodium perchlorate (Carlo Erba Reactifs) to block development. Metamorphosis was induced with 10 nM T, (Sigma) in the aquarium water. Animals were sacrificed by decapitation after anesthesia, dorsal muscles collected, flash frozen and stored at -80 C until used for assays. Plasmids and cRNA probes : Plasmids were propagated and purified by standard techniques: CsCl or Quiagen ionexchange columns. Plasmids for in vivo transfection were provided by Dr. R. Whalen (Institut Pasteur, Paris). For p-1443 myHCIIB-CAT (myHC-IIB, ref. 5), a fragment of the mouse adult myHC-IIB gene (position -1430 to +13) was cloned into pCAT-basic (Promega) upstream of the chloramphenicol acetyl transferase (CAT) sequence. pE1413CAT (Emb-myHC) contains approximately I .4 kb of 5' flanking sequence (position -1413 to +30) of the rat embryonic skeletal myHC gene linked to the CAT gene of puc9CAT (6). Luciferase activity driven by the cytomegalovirus (CMV) promoter of pcDNA3, (pCMV-luc) was kindly provided by Dr. M. Schleef (Quiagen, Germany). Negative controls for transcriptional regulation were the control vectors for both CAT expression plasmids (puc9CAT and pCAT-basic) and a SV40-CAT construct was used as a positive control (2). For RNase protection, cloned cDNAs for Xenopus embryonic (E3) and adult (A7) myHC mRNAs were gifts from Dr. G. P. Radice (University of Richmond, USA). Each myHC clone corresponded to the 3' end sequence of 630 pb (E3) and 1.5 kb (A7) of EcoRI-EcoRI fragment inserted into PGEM-7 (Promega) (7). The 5S clone pXp1, a kind gift from Dr. M. Logan (Medical Research Council, Mill Hill, UK) , contained the 321 nucleotides of the Xenopus 5S Hind111 fragment (8) cloned into the pKs HindIII site. Microinjection of DNA : Gene transfer in Xenopus tadpole dorsal muscle and enzyme assays (CAT, luciferase) were essentially as described (2). The injection solution (1 pl) contained 1.1 pg of DNA in 0.07 M NaCl, colored with fast green (Sigma). Transcription from 1 pg myHC constructs was normalized against cotransfected pCMV-luc (0.1 pg). For assay, muscles were sonicated in Tris-HCl buffer (0.25 M, pH 7.5) with phenylmethylsulfonyl fluoride (0.1 M) and aprotinin (5 units/ml). After centrifugation, supematants were assayed: CAT, according to Seed and Sheen (9) and luciferase using a commercial assay @omega). RNuse protection assay : Total RNA from tadpole dorsal muscle was prepared as described (10). Relative amounts of myHC transcripts were established by RNase protection assay using conditions described by Zinn et al. (11) with the 155 nt AvaII-EcoRI and the 155 nt HincII-EcoRI fragments of Xenopus E3 and A7 myHC cDNAs, respectively. Briefly, cRNA synthesis was carried out using linearized plasmids (1 pg), (a-32P)UTP (50 pCi, Amersham), unlabeled UTP (200 pM) and SP6 (for E3 and A7) or T3 (for 5s) polymerase (Boehringer) in 10 pl reaction volume (37 C, 90 min). DNA templates were digested with RNasefree DNase (Boehringer) for 20 minutes (37 C). Riboprobes were extracted with phenol-chloroform and precipitated (3x) with ammonium acetate (0.5 M final) to eliminate nucleotides. cRNA probes were diluted in 80% desionized formamide PIPES buffer and hybridized overnight in 30 ~1 (55 C) using 5.105 cpm per reaction to each dried down RNA. Unprotected probes were digested with 20 Kg/ml of RNaseA and 400 Units/ml of RNase Tl (RNase Cocktail, Ambion Inc, Austin, Texas, USA) for 45 mitt, 37 C. RNase was removed by adding SDS to 0.6% and proteinase K to 0.13 mg/ml (30 min, 37 C). Two pg of tRNA were added as a carrier, and the reaction mixture extracted with phenol-chloroform then precipitated with ethanol (1 h, 0 C). RNase-resistant products were recovered by centrifugation, resuspended in 10 pl formamide loading buffer, denaturated and run on 0.4 mm thick 6% acrylamide/6 M urea sequencing gels (1700 V for 2 hr). Autoradiography was performed at -80 C and quantification with a Phosphoimager (Molecular Dynamics). The 384 nt 5S cRNA and tRNA provided internal and negative controls respectively. I-WI-digested and HaeIII digested @x174 products (Eurogentec) were labeled by the kinase procedure and used as size markers. Normalization and statistical treatment of results : Results for RNase protection assays are expressed as arbitrary units, mean f SEM of three samples. For each sample, densitometry (Phosphoimager) readings for each lane were normalized against the quantity of total RNA and 5S RNA for that same sample. In vivo transfection results are given as fold induction over controls using means + SEM Student's t test was used to assess statistical differences between means.
ResultS
Analysis of myHC mRNAs : RNase protection assay was used to measure the relative amounts of embryonic (E3) and adult myosin (A7) in dorsal muscle as a function of thyroid status. Distinctive bands were seen for each probe when hybridized against extracts of larval dorsal muscle (Fig. 1) . Quantification was performed ,for each probe normalized against the 5S bands, which were not modified by the T, treatment (data not shown). The effects of T, treatment (24, 48 and 120 h) on expression of each myHC was analysed. As shown in Fig. 2A , decreased expression of E3 mRNA transcripts was observed over 120 h of T, treatment, and this drop was significant by 48 h. T3 induced a different expression profile for the A7 adult myHC mRNA. A7 mRNA was significantly increased by T? treatment at 48 h, but not different from controls at 24 and-120 h (Fig. 2B ). Transcriptional regulation in vivo : To assess whether the effects of Ts treatment were exerted at the transcriptional level we injected chimeric constructs containing the coding sequence of the CAT gene under the control of either a 1.4 kb 5' sequence of the rat embryonic myHC gene (EmbmyHC) or a 1.4 kb 5' sequence of the mouse myHC IIB promoter (myHC-IIB). CAT values were normalized for transfection efficiencies against luciferase measurements. Transcription of the luciferase construct (pCMV-luc) was not modifiedover time, nor as a function of T3 treatment (data not shown). Transcription from control vectors for both CAT expression plasmids (puc9CAT and pCAT-basic) was undetectable in control and T,-treated tadpoles (data not shown). Furthermore, no T,-dependent variations in expression of the positive control (SVQO-CAT) were found (data not shown). As shown in Fig. 2C , T, induced a 35-40% drop in transcription from the embryonic myHC promoter. Although the decrease was similar at all time points it only became significant at 120 h (p<O.O5), as at 24 and 48 h control values were highly variable. As to transcription from the adult myHC-IIB promoter, an overall lower level of expression was found. For 1 ktg of the embryonic form CAT values were 0.03 + 0.007 CAT units/muscle (mean f SEM) in control tadpoles, whereas 1 pg myHC-IIB gave 30x less (0.001 f 0.0003 CAT units/muscle). Though low, these levels were reproducible. T, modified transcription from the adult promoter, with different effects at each time point (Fig. 2D) . At 24 h T, was without effect, at 48 h a five fold, significant (p<O.O5), increase was seen, and after 120 h of treatment this increase was abrogated to a factor of two as compared to controls and was no longer significant. pCMV-Luc, 3 days before T, treatment, are expressed as fold induction where 1 equals control activity in the absence of T,. Each point represents the mean + SEM of 7 -10 animals. Statistical significance as compared with the untreated animals is expressed as *: ~~0.05 or **: p<O.Ol, calculated using Student's t test.
Discussion
Our aim in these experiments was to analyse whether heterologous, free DNA-based gene transfer could be used to follow T3-dependent transcriptional regulations in an integrated context. To this end, results obtained by examining T, regulation of exogenous myosin promoters transferred into Xenopus dorsal muscle were compared to those obtained on endogenous myHC genes in the same muscle. Both experimental approaches produced the same results in that the embryonic and adult myHC genes examined responded to T, in opposite manners. These parallel kinetics obtained by RNAse and somatic gene transfer provide a first step to validating the use of heterologous constructs for determining the roles of different transcription factors and cis-regulatory sequences within integrated contexts. The in viva gene transfer methodology used is a development of the original demonstration of Wolff et al. (12), who first showed that naked DNA could be used for gene transfer in mammalian skeletal muscle. Results obtained in our laboratory show that transfecting Xenopus muscle produces luciferase activities at least two orders of magnitude higher than those in the mammalian tissue. An analyse of factors accounting for the high uptake/expression of DNA in tadpole muscle would perhaps provide insight into ways of increasing gene transfer in the other systems. We examined the transcriptional regulation of chimeric genes coding for the CAT reporter gene under the control of the 5' sequence of either the rat Emb-myHC or the mouse adult myHC-IIB. Results obtained for the embryonic promoter showed that, at all time points examined, T, treatment decreased transcription from this promoter when injected into dorsal muscle. This inhibition was of the same order of magnitude as that seen for T, inhibition of E3 transcripts in the dorsal muscle. We have examined the nucleotide sequence of the rat Emb-myHC promoter (for sequence, see reference 6). In the first 100 base pairs there are three putative TR binding sites which are identical to the negative TRE (nTRE) halfsites recently described by Hollenberg et al. (13) in the rat TRH promoter, another gene negatively regulated at the transcriptional level by T, ( 14). Turning to the regulation of the adult myHC, again we find a time course of response to T, at the transcriptional level that is identical to that of levels of A7 transcripts followed by RNase protection assay. These transcriptional responses could be exerted through three TRE containing zones found in the myHC IIB (adult) promoter (5). The first region (-55 to -82) shows a direct repeat separated by 4 nts (DR4) as well as a palindromic TRE; the second area (-428 to -443) has a DR4 site and the third region (from -967 to -994) has a DR4 and two halfsites. For each of the DR4 sites, the 3' halfsite which binds the TR in a RXR/TR heterodimer (15) is a full octamer, which should provide high affinity for TR binding (16). These studies show that the mouse and rat myHC regulatory sequences can be used to follow control of transcription in viva in an integrated, though heterologous system. This may be due to a high degree of evolutionary conservation between promoter sequences. Good examples of cross species conservation in promoter sequences can be found in the two myogenic genes, myoD (17) and the myosin light chain MLClf/3f genes (18). Takeda and co-authors (19) have compared the regulatory sequences in the rat adult myHC-IIB promoter used in our study with those in the promoters of a family of chicken myHC skeletal genes. Certain sequences in the rat promoter revealed around 96% homology with the 5' region of one myHC expressed in both embryonic and adult chicken muscle. Homologous regions, based on sequence and position were also found in the promoters of five other chicken myHC genes (19). Similar findings have been reported by Chang et al. (20) . Working on broader comparisons and longer sequences (up to 1920 bases) these authors find homologies ranging from 46 to 67% between the porcine, avian and murine and rat myHC promoters. Like Takeda and co-authors they suggest these homologous regions could have been conserved through evolution, so as to serve roles in muscle specific regulation and possibly, developmentally-controlled expression. To determine if this is the case, direct in viva gene transfer into muscle at different developmental stages and in different species would provide an appropriate and powerful approach.
In conclusion, to fully validate this experimental system, transcriptional regulation of the mammalian promoters could be followed in mammalian skeletal muscle under different thyroid states. Conversely, the 5' sequences of the Xenopus myHC genes should be cloned and tested in Xenopus. However, the data as they stand argue strongly in favor of the usefulness of this experimental approach for the in vivo analysis of conserved evolutionary regulations of homologous genes at the transcriptional level. 
